Kali Zhou
Contact
American Cancer Society: Clinician Scientist Development Grant, 2022-2026
NIH/NIMHD: K23 Mentored Patient-Oriented Research Career Development Award, 2022-2026
American Cancer Society: Flatiron Real-World Data Impact Award, 2022-2023
American Cancer Society: Clinician Scientist Development Grant, 2022-2023
American Association for the Study of Liver Diseases: Clinical Translational and Outcomes Research Award, 2021-2023
American Association for the Study of Liver Diseases: Early Career Investigator Award in Clinical/Translational Science, 2021
American Association of Cancer Research : Scholar-in-Training Award, 2020
American Association for the Study of Liver Diseases : Early Career Investigator Award in Clinical/Translational Science, 2020
US Fulbright Program: Fulbright Scholar (China), 2014-2015
Northwestern University: Alpha Omega Alpha, 2011
Living-Donor Liver Transplant for Patients With End-stage Liver Disease JAMA Surg. 2023 Apr 01; 158(4):428. . View in PubMed
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study Hepatol Commun. 2023 01 01; 7(1):e8874. . View in PubMed
Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system Hepatol Commun. 2023 04 01; 7(4). . View in PubMed
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study Hepatol Commun. 2023 03 01; 7(3). . View in PubMed
Geographic hotspot detection for late-stage hepatocellular carcinoma: novel approach to cancer control Cancer Causes Control. 2022 May; 33(5):701-710. . View in PubMed
Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults Dig Dis Sci. 2022 07; 67(7):3340-3355. . View in PubMed
Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma Liver Transpl. 2022 05; 28(5):763-773. . View in PubMed
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-a "knock-out" is yet to be delivered Aliment Pharmacol Ther. 2022 05; 55(10):1342-1343. . View in PubMed
Diverging Incidence Trends for Hepatocellular Carcinoma in Rural and Urban Settings in the United StatesClin Gastroenterol Hepatol. 2022 05; 20(5):1180-1185. e2. . View in PubMed
Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation Clin Transplant. 2022 02; 36(2):e14527. . View in PubMed
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States Clin Gastroenterol Hepatol. 2022 01; 20(1):183-193. . View in PubMed
Acute Hepatitis A and Hepatitis B Coinfection ACG Case Rep J. 2021 Nov; 8(11):e00702. . View in PubMed
Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort Cancers (Basel). 2021 Jul 12; 13(14). . View in PubMed
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center StudyClin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479. e19. . View in PubMed
Discussion on "Causal mediation of semicompeting risks" by Yen-Tsung Huang Biometrics. 2021 12; 77(4):1165-1169. . View in PubMed
No Foul Play for Transjugular Intrahepatic Portosystemic Shunts in Liver Transplantation for Hepatocellular Carcinoma Liver Transpl. 2021 11; 27(11):1680-1681. . View in PubMed
Potential association between public medical insurance, waitlist mortality, and utilization of living donor liver transplantation: An analysis of the Scientific Registry of Transplant Recipients Clin Transplant. 2021 10; 35(10):e14418. . View in PubMed
Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma JNCI Cancer Spectr. 2021 02; 5(1). . View in PubMed
The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed JAMA Intern Med. 2021 03 01; 181(3):310-312. . View in PubMed
Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors Curr Opin Organ Transplant. 2020 12; 25(6):631-639. . View in PubMed
Downstaging to Liver Transplant: Success Involves Choosing the Right Patient Clin Liver Dis. 2020 11; 24(4):665-679. . View in PubMed
Mortality in adults with chronic hepatitis B infection in the United States: a population-based study Aliment Pharmacol Ther. 2020 07; 52(2):382-389. . View in PubMed
Gaps in Viral Hepatitis Awareness in the United States in a Population-based StudyClin Gastroenterol Hepatol. 2020 01; 18(1):188-195. e4. . View in PubMed
A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: A nationwide online randomized controlled trial EClinicalMedicine. 2019 Nov; 16:64-73. . View in PubMed
Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia Am J Gastroenterol. 2019 11; 114(11):1753-1763. . View in PubMed
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses Lancet Gastroenterol Hepatol. 2019 03; 4(3):227-238. . View in PubMed
New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus InfectionGastroenterology. 2019 01; 156(2):355-368. e3. . View in PubMed
A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: study protocol for a nationwide online randomized controlled trial BMC Infect Dis. 2018 Sep 29; 18(1):489. . View in PubMed
Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy? AME Med J. 2018 Feb; 3.. View in PubMed
Management of hepatitis B in special populations Best Pract Res Clin Gastroenterol. 2017 Jun; 31(3):311-320. . View in PubMed
Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses Lancet Infect Dis. 2016 Dec; 16(12):1409-1422. . View in PubMed
Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion Open Forum Infect Dis. 2016 Apr; 3(2):ofw065. . View in PubMed
Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China PLoS One. 2016; 11(6):e0157438. . View in PubMed
Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals BMC Public Health. 2016 09 20; 16:994. . View in PubMed
De novo Hepatocellular Carcinoma after Liver Transplantation J Clin Transl Hepatol. 2015 Dec 28; 3(4):284-7. . View in PubMed
Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study BMC Infect Dis. 2015 Sep 30; 15:401. . View in PubMed
Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infection J Clin Gastroenterol. 2014 Jul; 48(6):548-52. . View in PubMed
The role of point-of-care CT in the management of chronic rhinosinusitis: a case-control study Ear Nose Throat J. 2011 Aug; 90(8):376-81. . View in PubMed
Her current research program focuses on disparities in liver cancer and utilizing novel geospatial approaches to combat disparities in diverse populations. She is also grant funded to study the impact of immigration and acculturation on completing guideline-based HBV metrics and to pilot a need-based Lyft-rideshare intervention to improve time to listing among liver transplant candidates. Her career goal is to develop effective, pragmatic, and efficient interventions that will ultimately improve equity and outcomes for patients with liver disease.
